The expression of Rubicon is elevated in cancer and is strikingly associated with poor prognosis in patients with breast cancer, endometrial cancer, testicular cancer, liver cancer, colorectal cancer, and stomach cancer as shown in Figure 5 (95). The gene discussed is RUBCN; the disease is cancer.